Practical management of the haemorrhagic complications of myeloproliferative neoplasms

Br J Haematol. 2022 Nov;199(3):313-321. doi: 10.1111/bjh.18322. Epub 2022 Jun 20.

Abstract

Myeloproliferative neoplasms can be associated with bleeding manifestations which can cause significant morbidities. Although haematologists are aware of the likelihood of this complication in the setting of myeloproliferative neoplasms, it may often be overlooked especially in patients with no extreme elevation of blood counts and those with myelofibrosis. Acquired von Willebrand syndrome and platelet dysfunction are the two common diagnoses to be considered in this regard. In this review article, we discuss the mechanisms for the development of these rare bleeding disorders, their diagnosis and practical management.

Keywords: ET; MF; PV; acquired von Willebrand; myeloproliferative neoplasm; platelets.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Hemorrhage / complications
  • Hemorrhage / therapy
  • Humans
  • Myeloproliferative Disorders* / complications
  • Myeloproliferative Disorders* / therapy
  • Neoplasms* / complications
  • Primary Myelofibrosis* / complications
  • Primary Myelofibrosis* / diagnosis
  • Primary Myelofibrosis* / therapy
  • von Willebrand Diseases* / complications
  • von Willebrand Diseases* / therapy
  • von Willebrand Factor

Substances

  • von Willebrand Factor